
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers
Eman M. H. Abbas, Thoraya A. Farghaly, Rehab Sabour, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 13
Eman M. H. Abbas, Thoraya A. Farghaly, Rehab Sabour, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 13
Showing 13 citing articles:
A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 23
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 23
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)
Iryna Ivasechko, Andrii Lozynskyi, Julia Senkiv, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115304-115304
Open Access | Times Cited: 20
Iryna Ivasechko, Andrii Lozynskyi, Julia Senkiv, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115304-115304
Open Access | Times Cited: 20
An insight into therapeutic efficacy of heterocycles as histone‐modifying enzyme inhibitors that targets cancer epigenetic pathways
N. Jeelan Basha, S. M. Basavarajaiah
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 682-698
Closed Access | Times Cited: 24
N. Jeelan Basha, S. M. Basavarajaiah
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 682-698
Closed Access | Times Cited: 24
Discovery of novel indene-based hybrids as breast cancer inhibitors targeting Hsp90: Synthesis, bio-evaluation and molecular docking study
Amal M. Alosaimy, Amr S. Abouzied, Amani M.R. Alsaedi, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 4, pp. 104569-104569
Open Access | Times Cited: 15
Amal M. Alosaimy, Amr S. Abouzied, Amani M.R. Alsaedi, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 4, pp. 104569-104569
Open Access | Times Cited: 15
Synthesis, Cytotoxic, and Antioxidant Activity of Some Benzoquinoline-Based Heterocycles
Eman A. E. El‐Helw, Mahmoud Asran, Mohammad E. Azab, et al.
Polycyclic aromatic compounds (2023), pp. 1-13
Open Access | Times Cited: 12
Eman A. E. El‐Helw, Mahmoud Asran, Mohammad E. Azab, et al.
Polycyclic aromatic compounds (2023), pp. 1-13
Open Access | Times Cited: 12
Pro-Apoptotic and Mitochondria-Disrupting Effects of 4-methylthiazole in K562 Leukemia Cells: A Mechanistic Investigation
Neslihan Meriç, Ezgi Kar, Fatih Kar
Tissue and Cell (2025), pp. 102937-102937
Closed Access
Neslihan Meriç, Ezgi Kar, Fatih Kar
Tissue and Cell (2025), pp. 102937-102937
Closed Access
Anticancer Potential of Bioactive Molecule Luteolin and Its Analogs: An Update
N. Jeelan Basha, S. M. Basavarajaiah
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 5, pp. 3958-3976
Closed Access | Times Cited: 17
N. Jeelan Basha, S. M. Basavarajaiah
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 5, pp. 3958-3976
Closed Access | Times Cited: 17
Novel 6,7,8-trihydrobenzo[6',7']cyclohepta[2',1'-e]pyrazolo[2,3-a]pyrimidine derivatives as Topo IIα inhibitors with potential cytotoxic activity
Thoraya A. Farghaly, Hanan Gaber Abdulwahab, Hanadi Y. Medrasi, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106043-106043
Closed Access | Times Cited: 17
Thoraya A. Farghaly, Hanan Gaber Abdulwahab, Hanadi Y. Medrasi, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106043-106043
Closed Access | Times Cited: 17
Organocatalytic [3 + 2] Cycloaddition Reaction: Synthesis of Fully Decorated Sulfonyl-1,2,3-Triazolyl Pyrimidines as Potent Anticancer and EGFR Inhibitors
Jagan Mohan Reddy Velidandla, Shiva Kumar Koppula
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 4, pp. 2675-2687
Closed Access | Times Cited: 10
Jagan Mohan Reddy Velidandla, Shiva Kumar Koppula
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 4, pp. 2675-2687
Closed Access | Times Cited: 10
Synthesis and Characterization of New Mixed-Ligand Complexes; Density Functional Theory, Hirshfeld, and In Silico Assays Strengthen the Bioactivity Performed In Vitro
Farhi S. Alhazmi, Moataz Morad, Khlood S. Abou‐Melha, et al.
ACS Omega (2023) Vol. 8, Iss. 4, pp. 4220-4233
Open Access | Times Cited: 8
Farhi S. Alhazmi, Moataz Morad, Khlood S. Abou‐Melha, et al.
ACS Omega (2023) Vol. 8, Iss. 4, pp. 4220-4233
Open Access | Times Cited: 8
Thiadiazole-thiazole derivatives as potent anti-tubercular agents: Synthesis, biological evaluation, and In silico docking studies
Samin A. Shaikh, Shivaji R. Labhade, Raju R. Kale, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100183-100183
Open Access | Times Cited: 2
Samin A. Shaikh, Shivaji R. Labhade, Raju R. Kale, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100183-100183
Open Access | Times Cited: 2
One Pot Synthesis, Crystal Structure, Hirshfeld Studies, Docking Simulation and Antimicrobial Efficacy Assay of New Fused/Substituted Pyrazolinyl–Thiazolidinyl–Indolone Triheterocyclic Hybrid Scaffolds
Vinutha V. Salian, B. Narayana, B.K. Sarojini, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 8, pp. 5112-5137
Closed Access | Times Cited: 3
Vinutha V. Salian, B. Narayana, B.K. Sarojini, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 8, pp. 5112-5137
Closed Access | Times Cited: 3
Quinoline‐based thiazolyl‐hydrazones target cancer cells through autophagy inhibition
Vladimir Ćurčić, Mateusz Olszewski, Natalia Maciejewska, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 2
Vladimir Ćurčić, Mateusz Olszewski, Natalia Maciejewska, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 2
Synthesis of New Carbazole–Thiazole Analogues and Evaluating their Anticancer Activity
Mohamed R. Elmorsy, Mariam Eltoukhi, Ahmed A. Fadda, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 9, pp. 8048-8064
Closed Access | Times Cited: 2
Mohamed R. Elmorsy, Mariam Eltoukhi, Ahmed A. Fadda, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 9, pp. 8048-8064
Closed Access | Times Cited: 2